Cardiovascular complications after transplantation: Treatment options in solid organ recipients

被引:26
|
作者
Gillis, Keith A. [1 ]
Patel, Rajan K. [1 ]
Jardine, Alan G. [1 ]
机构
[1] Univ Glasgow, Renal Res Grp, Glasgow G12 8TA, Lanark, Scotland
关键词
RENAL-ALLOGRAFT RECIPIENTS; POSTTRANSPLANT DIABETES-MELLITUS; EARLY CYCLOSPORINE WITHDRAWAL; CONGESTIVE-HEART-FAILURE; LEFT-VENTRICULAR MASS; RISK-FACTORS; LONG-TERM; RANDOMIZED-TRIAL; KIDNEY-TRANSPLANTATION; LIVER-TRANSPLANTATION;
D O I
10.1016/j.trre.2013.12.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Premature cardiovascular disease is the commonest cause of death in solid organ transplant recipients, with coronary artery disease, sudden cardiac death and heart failure being highly prevalent. There are unique factors leading to CV disease in organ transplant recipients that include underlying comorbidities, and metabolic effects of immunosuppression. As a consequence management strategies developed in the general population may have limited benefit. In this review, we will focus on renal transplantation, where most research has been carried out and, despite incomplete understanding of the disease process, the incidence of cardiovascular disease appears to be falling. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [21] Renal disease in recipients of nonrenal solid organ transplantation
    Ojo, Akinlolu O.
    SEMINARS IN NEPHROLOGY, 2007, 27 (04) : 498 - 507
  • [22] Cardiovascular and renal complications in patients receiving a solid-organ transplant
    Diaz, Geraldine
    O'Connor, Michael
    CURRENT OPINION IN CRITICAL CARE, 2011, 17 (04) : 382 - 389
  • [23] Lymphoproliferative Disorders After Solid Organ Transplantation-Classification, Incidence, Risk Factors, Early Detection and Treatment Options
    Vegso, Gyula
    Hajdu, Melinda
    Sebestyen, Anna
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 443 - 454
  • [24] Late Cardiovascular Complications after Hematopoietic Cell Transplantation
    Chow, Eric J.
    Wong, Kenneth
    Lee, Stephanie J.
    Cushing-Haugen, Kara L.
    Flowers, Mary E. D.
    Friedman, Debra L.
    Leisenring, Wendy M.
    Martin, Paul J.
    Mueller, Beth A.
    Baker, K. Scott
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (06) : 794 - 800
  • [25] Subclinical cardiovascular changes in pediatric solid organ transplant recipients: A systematic review and meta-analysis
    Al Nasser, Yasser
    Moura, Marta C.
    Mertens, Luc
    McCrindle, Brian W.
    Parekh, Rulan S.
    Ng, Vicky L.
    Church, Peter C.
    Mouzaki, Marialena
    PEDIATRIC TRANSPLANTATION, 2016, 20 (04) : 530 - 539
  • [26] Bloodstream infections after solid-organ transplantation
    Kritikos, Antonios
    Manuel, Oriol
    VIRULENCE, 2016, 7 (03) : 329 - 340
  • [27] Management of Infectious Complications in Solid-Organ Transplant Recipients
    Grim, S. A.
    Clark, N. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (02) : 333 - 342
  • [28] Managing Cardiovascular Risk in the Post Solid Organ Transplant Recipient
    Munagala, Mrudula R.
    Phancao, Anita
    MEDICAL CLINICS OF NORTH AMERICA, 2016, 100 (03) : 519 - +
  • [29] Metabolic Consequences of Solid Organ Transplantation
    Bhat, Mamatha
    Usmani, Shirine E.
    Azhie, Amirhossein
    Woo, Minna
    ENDOCRINE REVIEWS, 2021, 42 (02) : 171 - 197
  • [30] Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation
    Brakemeier, Susanne
    Pfau, Anja
    Zukunft, Bianca
    Budde, Klemens
    Nickel, Peter
    PHARMACOLOGICAL RESEARCH, 2018, 134 : 61 - 67